(AGENPARL) – SILVER SPRING mar 30 maggio 2023 The FDA proposed a new, easy-to-read Medication Guide for patients. Patient Medication Information…
Browsing: Internazionali
(AGENPARL) – NEW YORK mar 30 maggio 2023 The following statement was issued today by the Spokesman for UN Secretary-General…
(AGENPARL) – mar 30 maggio 2023 None [1] Press service ** European Parliament ** Available in * None [2] None…
(AGENPARL) – KREMLIN mar 30 maggio 2023 The President answered a question by Director General of the Agency for Strategic Initiatives Svetlana Chupsheva on the drone attack on Moscow…
(AGENPARL) – BRISTOL (UK) mar 30 maggio 2023 The University of Bristol is part of a £42.7 million ‘Mental Health…
(AGENPARL) – KREMLIN mar 30 maggio 2023 On May 31, Vladimir Putin will hold talks with President of the State of Eritrea Isaias Afwerki, who…
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint Fonte/Source: http://www.fda.gov/drugs/accelerated-approval-program/verified-clinical-benefit-infectious-disease-accelerated-approvals-vaccines
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 Ongoing | Infectious Disease Accelerated Approvals (excluding vaccines) Fonte/Source: http://www.fda.gov/drugs/accelerated-approval-program/ongoing-infectious-disease-accelerated-approvals-excluding-vaccines
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint Fonte/Source: http://www.fda.gov/drugs/accelerated-approval-program/verified-clinical-benefit-infectious-disease-accelerated-approvals-excluding-vaccines
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint Fonte/Source: http://www.fda.gov/drugs/accelerated-approval-program/withdrawn-infectious-disease-accelerated-approvals